Jeremy G Chadwick insider trades

Open-market stock purchases and sales by Jeremy G Chadwick, Chief Operating Officer at Kymera Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2010.

Recent trades

DateStockTradeValue
May 27, 2026KYMR Kymera Therapeutics, IncSold$300K
May 27, 2026KYMR Kymera Therapeutics, IncSold$49.2K
May 26, 2026KYMR Kymera Therapeutics, IncSold$292K
May 26, 2026KYMR Kymera Therapeutics, IncSold$25.7K
May 26, 2026KYMR Kymera Therapeutics, IncSold$302K
May 26, 2026KYMR Kymera Therapeutics, IncSold$360K
May 26, 2026KYMR Kymera Therapeutics, IncSold$44.5K
Apr 22, 2026KYMR Kymera Therapeutics, IncSold$27K
Apr 22, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Apr 22, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Apr 15, 2026KYMR Kymera Therapeutics, IncSold$117K
Apr 15, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Apr 14, 2026KYMR Kymera Therapeutics, IncSold$473K
Apr 14, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Apr 14, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Apr 1, 2026KYMR Kymera Therapeutics, IncSold$1.2M
Apr 1, 2026KYMR Kymera Therapeutics, IncSold$94.7K
Apr 1, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 31, 2026KYMR Kymera Therapeutics, IncSold$649K
Mar 31, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 25, 2026KYMR Kymera Therapeutics, IncSold$2M
Mar 25, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 23, 2026KYMR Kymera Therapeutics, IncSold$1.7M
Mar 23, 2026KYMR Kymera Therapeutics, IncSold$4.1M
Mar 23, 2026KYMR Kymera Therapeutics, IncSold$644K

Companies traded

  • KYMR Kymera Therapeutics, Inc: 33 sales, last May 27, 2026
  • SNTA Synta Pharmaceuticals Corp: other filings, last Mar 1, 2010

Get free alerts when Jeremy G Chadwick files a new trade →